Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Avoid Hays (HAS) by Steve Moore in ShareProphets
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Strong Buy KEFI Gold and Copper (KEFI) by Tom Winnifrith in ShareProphets
- Buy Marks & Spencer Group (MKS) by Robert Stephens (The Times) in The Times - Tempus
- Add Land Securities Group (LAND) by Harvey Jones in The Motley Fool
- Hold Mincon Group (CDI) (MCON) by Hot Stock Rockets in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Watch Softcat (SCT) by Royston Wild in The Motley Fool
- Watch LondonMetric Property (LMP) by Harvey Jones in The Motley Fool
- Add Amaroq Minerals Ltd. Npv (DI) (AMRQ) by Tom Winnifrith in ShareProphets
- Buy Likewise Group (LIKE) by Hot Stock Rockets in ShareProphets
- Hold Foresight Group Holdings Limited NPV (FSG) by Tom Winnifrith in ShareProphets
- Hold Foresight Group Holdings Limited NPV (FSG) by Steve Moore in ShareProphets
- Avoid Focus Xplore PLC (FOX) by Tom Winnifrith in ShareProphets
- Buy City of London Inv Trust (CTY) by John Ficenec in The Times - Tempus
- Watch B&M European Value Retail S.A. (DI) (BME) by Zaven Boyrazian in The Motley Fool
- Hold Oxford Metrics (OMG) by Steve Moore in ShareProphets
- Hold Oxford Metrics (OMG) by Tom Winnifrith in ShareProphets
- Buy WPP (WPP) by Christopher Ruane in The Motley Fool
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
NOTE: This is based on 399 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : 1,599.00p | Latest Ask : 1,601.00p |
| High Today : 1,659.00p | Low Today : 1,590.00p |
| This Years High : 1,839.00p | This Years Low : 1,191.00p |
| Volume : 76,270 | MKT Cap : £3505.06M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-09-25 11:15:00 25/09/2026 | -1.31% |
| Buy | Jefferies | Premium Only | 2026-08-25 09:34:00 25/08/2026 | -3.06% |
| Buy | Citi | Premium Only | 2026-08-12 08:52:00 12/08/2026 | -3.06% |
| Buy | Berenberg | Premium Only | 2026-08-11 09:37:00 11/08/2026 | -3.17% |
| Buy | Deutsche Bank | Premium Only | 2026-08-10 09:41:00 10/08/2026 | -5.03% |
Hikma Pharmaceuticals (HIK) Recent Short Position Updates
| Position | Date |
|---|---|
| 1.29% | 14/09/2026 |
| 0.99% | 28/08/2026 |
| Latest Bid : 1,599.00p | Latest Ask : 1,601.00p |
| High Today : 1,659.00p | Low Today : 1,590.00p |
| This Years High : 1,839.00p | This Years Low : 1,191.00p |
| Volume : 76,270 | MKT Cap : £3505.06M |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-09-25 11:15:00 25/09/2026 | -1.31% |
| Buy | Jefferies | Premium Only | 2026-08-25 09:34:00 25/08/2026 | -3.06% |
| Buy | Citi | Premium Only | 2026-08-12 08:52:00 12/08/2026 | -3.06% |
| Buy | Berenberg | Premium Only | 2026-08-11 09:37:00 11/08/2026 | -3.17% |
| Buy | Deutsche Bank | Premium Only | 2026-08-10 09:41:00 10/08/2026 | -5.03% |